Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 1:30 pm Sale | 2025-09-30 | 13G | scPharmaceuticals Inc. SCPH | LYTTON LAURENCE W | 0 0.000% | -2,944,932 (Position Closed) | Filing History |
| 2025-11-12 2:52 pm Purchase | 2025-09-30 | 13G | scPharmaceuticals Inc. SCPH | Weiss Asset Management LP | 2,881,669 5.400% | 2,881,669 (New Position) | Filing History |
| 2025-11-10 08:41 am Sale | 2025-09-30 | 13G | scPharmaceuticals Inc. SCPH | Orin Hirschman | 0 0.000% | -4,200,577 (Position Closed) | Filing History |
| 2025-10-14 4:10 pm Unchanged | 2025-10-06 | 13G | scPharmaceuticals Inc. SCPH | TUDOR INVESTMENT CORP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-10-08 5:02 pm Sale | 2025-09-30 | 13G | scPharmaceuticals Inc. SCPH | KING LUTHER CAPITAL MANAGEMENT CORP | 2,128,391 4.000% | -1,540,779 (-41.99%) | Filing History |
| 2025-09-10 2:34 pm Purchase | 2025-09-02 | 13G | scPharmaceuticals Inc. SCPH | Glazer Capital, LLC | 2,474,820 4.640% | 2,474,820 (New Position) | Filing History |
| 2025-07-21 4:01 pm Purchase | 2025-06-30 | 13G | scPharmaceuticals Inc. SCPH | KING LUTHER CAPITAL MANAGEMENT CORP | 3,669,170 7.000% | 420,000 (+12.93%) | Filing History |
| 2025-04-28 4:01 pm Purchase | 2025-03-31 | 13G | scPharmaceuticals Inc. SCPH | KING LUTHER CAPITAL MANAGEMENT CORP | 3,249,170 6.500% | 268,760 (+9.02%) | Filing History |
| 2025-01-31 4:05 pm Purchase | 2024-12-31 | 13G | scPharmaceuticals Inc. SCPH | Orin Hirschman | 4,200,577 8.400% | 1,093,782 (+35.21%) | Filing History |
| 2025-01-28 10:56 am Purchase | 2024-12-31 | 13G | scPharmaceuticals Inc. SCPH | KING LUTHER CAPITAL MANAGEMENT CORP | 2,980,410 6.000% | 95,730 (+3.32%) | Filing History |
| 2024-11-15 4:06 pm Purchase | 2024-11-14 | 13G | scPharmaceuticals Inc. SCPH | KING LUTHER CAPITAL MANAGEMENT CORP | 2,884,680 5.800% | 561,390 (+24.16%) | Filing History |
| 2024-11-14 5:48 pm Sale | 2024-09-30 | 13G | scPharmaceuticals Inc. SCPH | Lundbeckfond Invest A/S | 2,863,987 5.700% | -319,999 (-10.05%) | Filing History |
| 2024-11-14 3:58 pm Purchase | 2024-09-30 | 13G | scPharmaceuticals Inc. SCPH | LYTTON LAURENCE W | 2,944,932 5.900% | 1,119,698 (+61.35%) | Filing History |
| 2024-10-30 4:05 pm Purchase | 2024-09-30 | 13G | scPharmaceuticals Inc. SCPH | KING LUTHER CAPITAL MANAGEMENT CORP | 2,323,290 4.600% | 22,400 (+0.97%) | Filing History |
| 2024-08-15 4:47 pm Purchase | 2024-08-13 | 13D | scPharmaceuticals Inc. SCPH | ORBIMED ADVISORS LLC | 6,059,528 12.100% | 500,000 (+8.99%) | Filing History |
| 2024-07-02 4:06 pm Purchase | 2024-06-30 | 13G | scPharmaceuticals Inc. SCPH | KING LUTHER CAPITAL MANAGEMENT CORP | 2,300,890 6.400% | 404,301 (+21.32%) | Filing History |
| 2024-05-20 4:05 pm Purchase | 2024-05-17 | 13G | scPharmaceuticals Inc. SCPH | KING LUTHER CAPITAL MANAGEMENT CORP | 1,896,589 5.300% | 1,896,589 (New Position) | Filing History |
| 2024-04-29 2:34 pm Purchase | 2024-04-17 | 13G | scPharmaceuticals Inc. SCPH | LYTTON LAURENCE W | 1,825,234 5.100% | 1,825,234 (New Position) | Filing History |
| 2024-04-05 12:21 pm Sale | 2024-03-31 | 13G | scPharmaceuticals Inc. SCPH | BlackRock Inc. BLK | 1,801,610 4.990% | -61,829 (-3.32%) | Filing History |
| 2024-02-14 4:25 pm Sale | 2023-12-31 | 13G | scPharmaceuticals Inc. SCPH | 5AM Ventures IV L.P. | 1,200,647 3.300% | -1,534,205 (-56.10%) | Filing History |